Firefly Neuroscience (AIFF) EBT Margin (2010 - 2026)
Firefly Neuroscience (AIFF) posted EBT Margin of 385.99% for Q2 2026, up 6.58% on a QoQ basis from 413.2% in Q1 2026, and up 22571.0% year-over-year from N/an in Q2 2025.
Powered by 
Analysis
Firefly Neuroscience (AIFF) EBT Margin (2010 - 2026) Analysis & Trends
Firefly Neuroscience has reported EBT Margin for 16 years, with the latest figure at 385.99% in Q2 2026.
- On a quarterly basis, EBT Margin rose 22571.0% year-over-year to 385.99% in Q2 2026; TTM through Jun 2026 was 506.17%, a 517879.0% increase from a year earlier, with the FY2025 full-year figure at 1740.54%, up 794279.0% from the prior year.
- EBT Margin was 385.99% for Q2 2026 at Firefly Neuroscience, up from 413.2% in the prior quarter.
- The five-year high for EBT Margin was 22.54% in Q2 2023, with the low at 30069.77% in Q1 2025.
- Average EBT Margin over 5 years is 4341.69%, with a median of 601.7% recorded in 2025.
- The sharpest annual moves came in 2025 and 2026: EBT Margin slumped 2071977 bps in 2025, then jumped 2965657 bps in 2026.
- Over 5 years, EBT Margin stood at 52.34% in 2022, then plunged by 10720 bps to 5663.16% in 2023, then tumbled by 114 bps to 12136.36% in 2024, then soared by 95 bps to 601.7% in 2025, then jumped by 36 bps to 385.99% in 2026.
- The last three EBT Margin figures came in at 385.99% (Q2 2026), 413.2% (Q1 2026), and 601.7% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 13.09% |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 24.17% |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | -24.53% |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -5.37% |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | -39.59% |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | -68.58% |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 7.70% |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | -385.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -385.99% |
| Mar 31, 2026 | -413.20% |
| Dec 31, 2025 | -601.70% |
| Sep 30, 2025 | -680.15% |
| Jun 30, 2025 | -611.71% |
| Mar 31, 2025 | -30,069.77% |
| Sep 30, 2024 | -12,136.36% |
| Jun 30, 2024 | -10,845.45% |
| Mar 31, 2024 | -9,350.00% |
| Dec 31, 2023 | -5,663.16% |
| Sep 30, 2023 | -2,826.09% |
| Jun 30, 2023 | 22.54% |
| Mar 31, 2023 | -45.83% |
| Dec 31, 2022 | -52.34% |
| Sep 30, 2022 | -49.75% |
| Jun 30, 2022 | -43.16% |
| Mar 31, 2022 | -56.61% |
| Dec 31, 2021 | -98.94% |
| Sep 30, 2021 | -2.22% |
| Jun 30, 2021 | 0.91% |